Clostridium difficile infection (CDI) due to polymerase chain reaction (PCR) ribotype 027 (type 027) has been described worldwide [1] [2] [3] [4] . This strain harbors the toxin genes tcdA and tcdB as well as binary toxin genes, and has a deletion at position 117 in the toxin regulatory gene tcdC, which is associated with increased virulence [5] . C. difficile strains lacking toxin A (A-/B1) are also increasingly found to cause outbreaks, especially in some Eastern European countries, South America, and Asia [6] [7] [8] [9] [10] [11] [12] . The most commonly found A-/B1 strain belongs to PCR ribotype 017 (type 017) [7] . Although several outbreaks of CDI due to type 017 have been reported, it is unclear whether the clinical characteristics, spread, response to therapy, and outcome differ from outbreaks due to other C. difficile types [6, 11] .
We encountered a unique CDI outbreak due to type 027 and type 017 occurring simultaneously in a 980-bed teaching hospital in the Netherlands. In response, we performed a case-control study to investigate typespecific risk factors and outcome of CDI patients, compared with control patients without diarrhea. Risk factors for diarrhea in general were also analyzed by inclusion of a control group of diarrheal patients without CDI. Finally, we studied clonal dissemination using multilocus variable number tandem repeat analysis (MLVA).
METHODS

Study Design
The medical ethics committee and the institutional board of the hospital approved the study. We included all consecutively diagnosed CDI patients with a positive feces toxin test and culture of C. difficile from May 2005 through January 2007. For every CDI patient, we randomly selected a control patient without diarrhea, matched for ward, age, sex, admission period, and duration of hospitalization. We also included a group of control patients with non-CDI diarrhea, as determined by a negative C difficile toxin assay. We matched these patients for ward and date of toxin testing, but because of an insufficient number of available controls, not for age, sex, or duration of hospitalization.
Microbiological Analysis
We tested diarrheal fecal samples from hospitalized patients with a rapid enzyme immunoassay (ImmunoCard Toxin A and B [ICTAB]; Meridian). This test was selected because of its easy use and good performance in comparison with cell cytotoxicity and real-time PCR [14] . All toxin test-positive stool samples were cultured for the presence of C. difficile using previously described methods, and isolates were further investigated by PCR ribotyping [15, 16] . A randomly selected number of isolates were tested for antimicrobial susceptibility to ciprofloxacin, moxifloxacin, erythromycin and clindamycin, using E tests. We defined resistance to all 4 antibiotics at $ 4 mg/l [17] . Molecular genotyping was performed by multilocus variable-number tandem-repeat analysis (MLVA) and minimum spanning tree (MST) analysis was used to determine the genetic distance between isolates [18] . We used the number of differing loci and the summed tandem-repeat difference (STRD) between MLVA types as coefficients for the genetic distance, using the BioNumerics software program (version 4.6, Applied Maths). Genetically related complexes were defined by a STRD # 10 and clonal complexes by a STRD # 2 [8, 19] .
Clinical Analysis
CDI was defined as diarrhea in combination with a positive laboratory assay for C. difficile toxin A or B in stools. Diarrhea was considered as severe when it occurred in combination with 1 or more of the following: bloody stools, hypovolemia, hypoalbuminemia (,20g/L), fever (T . 38.0°C), leukocytosis (white blood cell count . 12 3 10 9 cells/L), and pseudomembranous colitis. For each death, 2 physicians (A. G. and J. C. D.) reached consensus about whether CDI was the direct cause of death (attributable mortality), contributed (contributable mortality) to the death, or was not related to death. We collected patient information on age, sex, ward of acquisition, disease severity, mortality and Charlson comorbidity index on admission [13] . Data were collected on procedures (endoscopy, abdominal surgery), previous admissions, and use of antibiotics and medications during the 3 months prior to the first CDI episode. This period was determined by calculating backward from a reference date. For CDI and non-CDI diarrheal patients, this reference date was defined as the day on which the diarrhea started. For nondiarrheal control patients, we determined the reference date by adding the hospitalized period of the matched CDI patient (time between admission and start of diarrhea) to the admission date of the control patient.
We assessed comorbidity using the International Classification of Diseases 10 (ICD-10) classification. For each prescribed antibiotic, defined daily dose (DDD) was calculated according to the World Health Organization (WHO ) recommendation (calculator available at http://www.escmid.org/research_projects/study_ groups/esgap/abc_calc/). Low exposure to antibiotics was defined as the use of ,3 DDDs of a certain antibiotic, and high exposure to antibiotics as the use of $3 DDDs.
Statistical Analysis
To compare risk factors for CDI with risk factors for diarrhea in general, we compared the distribution of risk factors among patients with CDI diarrhea and with non-CDI diarrhea with the distribution among nondiarrheal control patients. Relative risk was expressed as an odds ratio (OR) with a 95% confidence interval (95% CI).
Because nondiarrheal control patients were matched to case patients for potential risk factors, a conditional logistic regression analysis was performed that took this matching fully into account. The comparisons between non-CDI diarrheal patients and nondiarrheal control patients, as well as comparisons of CDI caused by different PCR ribotypes were analyzed by unconditional logistic regression analysis.
When a patient died who had lived within the community boundaries, the hospital received notification from the community council. For this subgroup of patients, the vital status was certain at the end of follow-up. To determine the overall 30-day mortality, we therefore only included this subgroup of patients.
In the multivariable model, we always adjusted for age, sex, and ward, except in the matched analysis between CDI patients and nondiarrheal control patients where these factors were taken into account by the matching. For the analysis of the effect of antibiotics and other medications, we additionally adjusted for comorbidity and use of comedication. All analyses were performed using the Statistical Package for the Social Sciences (SPSS) for Windows software, version 16.0.
RESULTS
In July 2005, CDI occurred among 20 patients, and a CDI outbreak was recognized, with an increased incidence of 101 cases per 10 000 admissions. Predominantly affected were the departments of hematology, nephrology, and general surgery. Although implementation of infection control measures (disinfection, isolation, cohort nursing, antibiotic stewardship) resulted in a decrease in incidence, several new peaks were noticed following the release of these measures, forcing their reimplementation. After introducing a restriction on the use of fluoroquinolones and cephalosporins in June 2006, the incidence finally decreased to around 30 cases per 10 000 admissions in early 2007.
Microbiology
Isolates from 168 of 223 patients with CDI (75%) were available for PCR ribotyping. Of these, 57 patients (34%) had type 017, 46 (27%) had type 027, and 65 (39%) had a type other than 017 or 027. Within this last group, the following types were found: 014 (14 patients), 001 (6), 078 (5) (1), and unknown types (18) .
We performed susceptibility testing on a random selection of 19 type-027 isolates and 19 type-017 isolates. All type-017 and type-027 isolates were resistant to ciprofloxacin (minimum inhibitory concentration [MIC] . 32 mg/L). All type-017 isolates and 18 type-027 isolates (94.7%) were resistant to erythromycin (MIC . 256 mg/L). Resistance to moxifloxacin was found among 17 (89.4%) of both the type-017 and type-027 isolates. Resistance to clindamycin was found among 18 (94.7%) type-017 isolates (MIC . 256 mg/L), whereas all type-027 isolates had MICs #4 mg/L for clindamycin.
In total, 108 isolates of 168 CDI patients (64%) were available for investigation by MLVA: 33 type-027 isolates, 42 type-017 isolates, and 33 isolates that belonged to other types. MST analysis of the type-017 and type-027 isolates is depicted in Figure 1 . Of the 33 type-027 isolates, 32 (97%) were genetically related (STRD # 10), and among these isolates, 3 clonal complexes (STRD # 2) were found (boxed clusters CC-A through CC-C). In total, 25 (76%) of the type-027 isolates belonged to a clonal complex. Similarly, 41 of the 42 type 017 isolates (98%) were genetically related and 4 clonal complexes (CC-D through CC-G) were found, comprising 37 of the type-017 isolates (88%). In contrast, no clonal complexes were found among 10 type-014 isolates and only 3 (30%) were genetically related (not shown in Figure 1 ). Among 23 isolates that belonged to types other than 014, 017, or 027, 1 clonal complex was found, comprising 2 isolates belonging to type 070 (not shown in Figure 1 ). Clonal spread of types 027 and 017 was predominant on the wards of geriatrics (CC-B), internal medicine, and Surgery (CC-A, CC-D, CC-E, CC-F). Clonal complexes persisted on these wards for a maximum of 12 months (CC-D) and persisted throughout the hospital for a maximum of 18 months (CC-A).
Clinical Analysis
Risk Factors
General risk factors are shown in Table 1, whereas Table 2 depicts odds ratios (ORs) for specific antibiotics. Patients With CDI Versus Nondiarrheal Control Patients Significant crude risk factors were discharge from the hospital in the month before the current admission, colonic diseases, abdominal surgery, complications of surgical care, nasogastric intubation, and any use of antibiotics. In the adjusted model, the association with recent discharge became weaker, whereas the association with use of antibiotics became stronger (increase in OR from 8.33 to 12.6). Specific antibiotics exposures associated with an increased risk were low and high exposure to second-generation cephalosporins and high exposure to clindamycin. In the adjusted model, the association with penicillins disappeared, whereas the association with high exposure to second-generation cephalosporins and clindamycin remained statistically significant (the OR for clindamycin increased from 5.17 to 8.79). Finally, control patients had significantly higher Charlson comorbidity indices than those of CDI patients (matching effect; Charlson scores not shown in Table 1 ). Patients With Non-CDI Diarrhea Versus Nondiarrheal Control Patients Significant risk factors, in both crude and adjusted models, were inflammatory bowel disease and abdominal surgery. Use of any antibiotics was also a significant risk factor in the adjusted model (increase in OR from 1.86 to 2.56). Specifically, low exposure to first-generation cephalosporins was associated with and increased risk, both in the crude and in the adjusted model.
Patients with non-CDI diarrhea were significantly younger (19% vs 36% older than 80 years) and had a lower Charlson comorbidity index. Patients With Type-027 CDI Versus Patients With CDI Due to Other Types (Non-027/Non-017) Significant risk factors, in both crude and adjusted models, were older age and hematological malignancy (Table 3) . High exposure to ciprofloxacin was specifically associated with type-027 CDI (Table 4) . Patients With Type-017 CDI Versus Patients With CDI Due to Other Types (Non-027/Non-017) Significant crude risk factors were male sex, higher Charlson comorbidity score, and use of immunosuppressive agents. All these factors, except male sex, remained statistically significant in the adjusted model. Hematological malignancy (increase in OR from 3.83 to 4.78) was also a significant risk factor in the adjusted model. Regarding antibiotic exposure, high exposure to clindamycin was specifically associated with type-017 CDI, which remained statistically significant in the adjusted model, with an increased OR from 2.24 to 3.56.
Clinical Course and Outcome
Compared with non-CDI diarrheal patients, patients with CDI more often had severe diarrhea: 47.8% versus 25.7% (adjusted OR 3.06; 95% CI 1.58-5.92).
As shown in Table 5 , patients with CDI had a higher 30-day mortality than both non-CDI diarrheal patients and nondiarrheal control patients. As shown in table 6, the attributable in-hospital mortality rates among patients with CDI types 027 and 017 were higher than the rate among patients with other types (not significant). Patients with type 027 or 017 had Figure 1 . Minimum spanning tree analysis of Clostridium difficile isolates typed by multilocus variable-number tandem-repeat analysis (MLVA): 33 type-027 isolates (in blue circles) and 42 type-017 isolates (in green circles). Each circle represents either a unique isolate or more isolates that are 100% homologous. The numbers between the circles represent the summed tandem-repeat difference (STRD) between MLVA types. Within the spanning tree, genetically related complexes (STRD # 10) are marked in grey. Clonal complexes (CC-A to CC-G) with a STRD # 2 are marked in yellow. Isolates are marked according to the ward where CDI was diagnosed and date of diagnosis (mm-yy). Abbreviations: IM1, internal medicine, ward 1 (department of hematology); IM2, internal medicine, ward 2 (department of nephrology); IM3, internal medicine, ward 3; IM4, internal medicine, ward 4; S1-4, surgery, wards 1-4; Ca, cardiology; IC, intensive care; G, geriatrics; U, urology; P, pulmonology. Example: IM1 6-5 stands for ''internal medicine, ward 1, June 2005.'' similar overall mortality rates after 30 days, which were significantly higher than the mortality rate observed among patients with CDI due to other types.
DISCUSSION
We experienced an outbreak with 2 different C. difficile PCR ribotypes (types 017 and 027), which occurred simultaneously at the departments of internal medicine, geriatrics, and general surgery in 1 hospital in the Netherlands. Using MLVA, we discerned a pattern of clonal dissemination of types 027 and 017. Transmission occurred despite appropriate infection control measures, with prolonged presence of clones on wards and throughout the hospital for .1 year. Several factors may have contributed to failure to control the outbreak. Per ward, only a limited number of single rooms was available. Until patients with CDI were sequestered on a separate C. difficile ward, CDI patients who sojourned in 2-or 4-patient rooms were placed in contact isolation in single rooms, often on another ward. This exchange of CDI patients may explain the observation of repeated small outbreaks on several wards. Second, use of clindamycin was not restricted, which may have affected the incidence of C. difficile type 017. During the study period, we observed no significant increase in the overall incidence of hospital-acquired infections due to vancomycinresistant Enterococcus (only 3-9 clinical isolates per year), norovirus, or extended-spectrum b-lactamase-producing Gramnegative bacteria. In the first months of 2005, an outbreak due to methicillin-resistant Staphylococcus aureus (MRSA) occurred in the geriatric department, which was related to an outbreak in an adjacent nursing home. The outbreak was controlled soon after implementation of intensive MRSA outbreak control measures.
The setting of this outbreak provided a unique opportunity to study PCR ribotype-specific risk factors, clinical presentation, and outcome of CDI. The inclusion of a non-CDI diarrheal control group enabled us to discriminate between risk factors for CDI and for diarrhea in general, which may be of importance in outbreaks (when specific infection control measures are considered) and in epidemiological studies. Risk factors for CDI included increased comorbidity, hematological malignancy, nasogastric intubation and use of antibiotics, especially high exposure to cephalosporins and clindamycin. These factors have previously been recognized, although studies lacked appropriate control groups of non-CDI diarrheal patients [20] [21] [22] [23] . Risk factors for diarrhea were prior abdominal surgery, coexisting diseases of the digestive system, and low exposure to first-generation cephalosporins (generally prescribed as perioperative prophylaxis).
In this study, risk factors for type-027 CDI differed from risk factors for type-017 CDI, although patients were nursed on similar departments and did not differ in age or comorbidity. Interestingly, high exposure to fluoroquinolones was a specific risk factor for type 027, whereas high exposure to clindamycin was a specific risk factor for type 017. In contrast to 027 isolates, 95% of the 017 isolates were resistant to clindamycin, supporting the hypothesis that differential susceptibility correlates with exposure rates. This is not applicable for the association of type 027 with fluoroquinolones, because strains of both type 027 and type 017 were resistant. Possibly, to a lesser extent, fluoroquinolones also increase the risk to develop CDI due to type 017 (adjusted OR was 1.5), but our study was too small to reach statistical significance. Other possible explanations are that fluoroquinolones influence the host defense against type 027 by specific changes of the microbiota or increase spread of type 027 by enhanced sporulation.
An interesting finding in this study was the high 30-day mortality rate among patients with CDI due to types 017 and 027 (23% and 26%, respectively); the rate for CDI caused by other types was only 3% and comparable to the 30-day mortality for non-CDI diarrheal patients and nondiarrheal control patients. The first explanation for this large difference is that infections with PCR ribotypes 027 and 017 are markers of underlying disease severity. Although Charlson comorbidity indices at baseline did not differ, we were not informed about the severity of underlying disease during and after admission, which is not taken into account by this score. A second possible explanation is that mortality depends on the involved PCR ribotype, as was also recently described by Miller et al, who found that among patients aged 60-90 years, those with type-027 CDI were twice as likely to die as those with non-type-027 CDI [24] . By contrast, in 2 studies, type 027 was not associated with adverse outcome; however, one described an endemic setting with type-027 CDI, and the second study did not compare CDIs caused by different types [25, 26] . An asterisk indicates statistical significance. a Data only from patients who had lived within the community boundaries (of these patients, the hospital received a notification of death from the community council, so the vital status was certain at the end of follow-up). The two numbers that are shown in the n columns reflect the number of patients that died on the total number of patients that lived within the community boundaries (numerator/denominator). In another recent study, the independent impact of hospital acquired CDI on in-hospital mortality was investigated, after adjusting for the time-varying nature of CDI and baseline mortality risk at hospital [27] . On average, patients with CDI had a 3-fold increased risk of death. In this study, the strain-type that caused CDI was not taken into account. However the results of this study match those that we found for the outbreak strains, types 017 and 027, which suggests that our findings are probably not unique for this hospital.
In this outbreak setting, type 017 was associated with similar clinical presentation and outcomes as type 027. This is surprising, because type 017 lacks toxin A gene and contains none of the proposed virulence markers typical of type 027. We hypothesize that yet unknown virulence markers might be involved, such as variants of TcdB, or non-toxin-related virulence factors. In a very recent study applying comparative genome analysis of 14 sequences strains, we found SNPs that were found in 2 candidate genes with yet-unknown functions were associated with severe CDI [28] . Interestingly, these SNPs were found to be present among type 027 strains, but also among type 017 strains that lacked toxin A.
Limitations of our study are firstly that we had to perform a matched analysis in the comparison between patients with CDI and nondiarrheal control patients to take possible confounding into account introduced by the matching [29] . The resulting loss of power may have obscured other significant associations. Second, non-CDI diarrheal patients could have falsely tested negative for CDI, due to lack of sensitivity of the applied diagnostic test. However, almost all these patients were repeatedly tested negative and none developed CDI at a later stage. Finally, we could assess mortality only in a limited number of patients and although the observed differences were statistically significant, the confidence intervals were wide. The high 30-day mortality among CDI patients therefore warrants more detailed investigation, specifically aimed at attributable and contributable mortality at longer-term follow-up. An asterisk indicates statistical significance. a Data only from patients who had lived within the community boundaries (of these patients, the hospital received a notification of death from the community council, so the vital status was certain at the end of follow-up). The two numbers that are shown in the n columns reflect the number of patients that died on the total number of patients that lived within the community boundaries (numerator/denominator).
Notes
